Diahnn Futalan

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma

Jie Li, Shan Zhu, David Kozono et al. · Oncotarget · 2014 · 146 citations · Full text

Medicine, Oncology, Radiation Oncology +17

TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant

Rebecca Saenz, Diahnn Futalan, Lien Leutenez et al. · Journal of Translational Medicine · 2014 · 99 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Delivery of a peptide via poly(d,l-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell–stimulatory capacity

Corbin Clawson, Chien-Tze Huang, Diahnn Futalan et al. · Nanomedicine Nanotechnology Biology and Medicine · 2010 · 87 citations · Full text

Pharmacy, Immunology, Pharmaceutics +14

Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53

Jessie-F. Fecteau, Laura G. Corral, Emanuela M. Ghia et al. · Blood · 2014 · 86 citations · Full text

Life Sciences, Oncology, Pharmacology +16

A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas

Deepa Kushwaha, Valya Ramakrishnan, Kimberly Ng et al. · Oncotarget · 2014 · 73 citations · Full text

Medicine, Oncology, Radiation Oncology +16